In this official NVIDIA Success Story, Innophore demonstrates how GPU-accelerated computing, the BioNeMo framework, and Amazon Web Services are revolutionizing drug discovery workflows. By leveraging NVIDIA GPUs and RAPIDS, Innophore reduced the computation time for protein-ligand interaction predictions from 2,000 CPU hours to just 15 minutes — at 5% of the original cost. The case study highlights how the CavitomiX platform processed over 15 million SARS-CoV-2 structural variants, enabling researchers to predict the emergence of new virus variants before they become dominant.